A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding.
about
Expression of the human glucokinase gene: important roles of the 5' flanking and intron 1 sequencesHepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.Molecular mechanism of hepatitis C virus-induced glucose metabolic disordersHepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.Hepatocyte nuclear factor 1 is essential for transcription of sodium-dependent vitamin C transporter protein 1FoxOs function synergistically to promote glucose production.Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.Decreased expression of hepatic glucokinase in type 2 diabetes.Higher protein kinase C ζ in fatty rat liver and its effect on insulin actions in primary hepatocytesUpregulation of Scavenger Receptor BI by Hepatic Nuclear Factor 4α through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism in Liver.Impairment of hepatic nuclear factor-4α binding to the Stim1 promoter contributes to high glucose-induced upregulation of STIM1 expression in glomerular mesangial cellsA mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolismTranscriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy MetabolismMenin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment.Non-transcriptional Function of FOXO1/DAF-16 Contributes to Translesion DNA Synthesis.Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.Sirtuin biology and relevance to diabetes treatment.Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.Insulin Is Required to Maintain Albumin Expression by Inhibiting Forkhead Box O1 ProteinDose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1AMP-activated protein kinase and its downstream transcriptional pathwaysFoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol.Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins.FOXO transcription factors protect against the diet-induced fatty liver disease.Transcriptional regulation of energy metabolism in the liver.AMP-activated protein kinase modulators: a patent review (2006 - 2010).Gut-liver interaction in triglyceride-rich lipoprotein metabolism.Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.Insulin-Mediated Downregulation of Apolipoprotein A-I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors.Liver X receptor α is involved in the transcriptional regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesisAdenovirus vector-mediated macrophage erythroblast attacher (MAEA) overexpression in primary mouse hepatocytes attenuates hepatic gluconeogenesis.Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
P2860
Q28727679-8EB169DC-C67C-4DF9-BF0C-44A63336688BQ30395512-8D48127C-980B-4CE0-9CD7-4991CE12A5F1Q30395601-9BCB13E4-C189-4880-9048-88700F81222DQ33680916-80DC7FD8-280A-4469-B724-B71195CEBCABQ33681069-4F66BE15-D521-483E-B76D-5B284F57AAC8Q34284954-78DAFCF2-5428-4A5D-BCBE-BB7E9B33C111Q34289895-1A001518-0869-49A1-AE76-BE84382A96CEQ34339449-E93E329E-BA41-4B1A-A33C-F1AB5D231E39Q34981792-18B4D57C-FEE2-4B94-89C6-EE9BAB4CE87CQ35113468-77128051-4471-4FF1-8933-7E27CF86360AQ35231302-451E95E5-5E28-43B1-A63D-29436F102362Q35609008-1FEBCED8-3C8B-47B1-825E-4625D4B7E5C1Q35622475-C639E1BD-F7EF-4C6D-950B-C013863FBF02Q35630807-FE393168-1C2B-4DF2-8727-CCADD90B7BC8Q35796349-1559648A-5EF9-4F0C-8A98-44558DF9FA7FQ35803413-97581E70-4CCA-4E7A-B73E-41B5870FDBDCQ35814179-765461BE-B6E7-4673-BCB2-6372210B276AQ36004187-BCB7A656-DFBC-4C99-A174-96BDAED12197Q36109887-25937C73-4959-44A2-9C4A-CFC1A8E9B574Q36182573-5B98221B-617B-4FD6-86F1-E29BBA38ADBDQ36281133-D9805605-918F-4982-80C9-16B18C919E7FQ36478114-7196A65D-E70F-4AB9-8C70-9435835C62E2Q36518326-5DBBC0C7-ED08-4455-AF00-285D4442394BQ36530674-C513F65B-6F8D-4B0D-8DAD-846661BFD1A9Q36756228-1B72C687-4181-4AF5-9034-FAA73C68158AQ37431323-EF6DEC70-532F-4430-9AAC-709495108AEBQ37693826-33E7D3FC-0BC4-49E5-A790-FFA833BF7CEAQ37704641-40641D81-9B7C-43FB-A53C-86EB5E6FE0B2Q37782072-B1FD9E67-65B7-4811-987B-32F2F301E851Q37872742-CA1E83FC-76E0-4BAE-A854-E17753862537Q37892758-324D6A63-B5E5-40FF-B18A-87BC93B62E0CQ38309913-D629E9C7-B922-444D-91A2-129B17D44C42Q38344552-824D218D-82B3-457B-BD90-C4093F455A48Q38728466-5CE4A140-C7BA-4DB7-AEF6-97D4D6C1F138Q38758630-62E625F4-1F8A-480D-8AEE-0B9B8AD0F352Q39380086-55D00D4E-E9CD-4F4D-825E-55D3620A72FDQ39760187-863829A3-63F2-4DCE-809E-04512DAD39B0Q39881165-156F0A08-6FD2-40E5-9173-D3D2C654F4D9Q41682189-91C82968-11D4-4E37-BF40-4D056F01EA23Q42056919-093D550B-C5CA-417A-8502-0101AE334CD0
P2860
A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@en
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@nl
type
label
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@en
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@nl
prefLabel
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@en
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@nl
P2093
P2860
P356
P1476
A combination of HNF-4 and Fox ...... sponse to fasting and feeding.
@en
P2093
Akiyoshi Fukamizu
Jun-ichi Sakamaki
Junji Ishida
Kazuhide Ohta
Keiji Tanimoto
Keiko Hirota
Masayuki Yamamoto
Norio Kodama
Shigeki Nishihara
Yoko Shimamoto
P2860
P304
32432-32441
P356
10.1074/JBC.M806179200
P407
P577
2008-09-19T00:00:00Z